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                                            INTRODUCTION 
      Renal cell carcinoma is a common urological cancer. Patients usually presents 
with loin pain and haematuria. CT and MRI are the two important investigations 
that are available to diagnose and stage renal masses. The density of a renal mass 
and its intensity on unenhanced imaging and the presence of enhancement after 
contrast administration has been used to determine the nature of renal masses.  
     In case of a cystic renal mass, the Bosniak classification uses the CT or MR 
imaging appearances and it stratifies the risk of malignancy associated with the 
renal cyst. In the recent times ,contrast CT has been used to differentiate clear cell 
renal cancer from papillary renal cell cancer in which the later usually has a 
homogenous appearance whereas the former has a heterodense appearance . 
  Inspite of these investigations there are no imaging techniques that easily 
differentiate the benign renal mass from the malignant which is shown by the fact 
that about 20% of nephrectomies are done on benign lesions .Therefore, 
preoperative imaging studies would play an important diagnostic role if they could 
be used to precisely differentiate between the two categories of renal masses . 
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  Diffusion weighted MRI is being used in neuroradiology for the diagnosis 
of differentiation between the benign and malignant tissue. The diffusion of 
molecules within the cell follows Brownian movement. The highly cellular 
malignant tissue has restricted diffusion and the benign lesions have a high 
diffusion coefficient.  The restricted diffusion images have a low ADC value and 
the benign lesions have high ADC value. 
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                                        AIM OF THE STUDY          
 
To predict the histopathological nature of renal masses by using Diffusion 
weighted Magnetic Resonance Imaging (DW MRI) 
To study the correlation of DW MRI findings with clinical, radiological and 
pathological findings. 
 
 
 
 
 
                                       
 
 
 
 
4 
 
                                      REVIEW OF LITERATURE 
 Kidneys are  retroperitoneal organs located in the dorsal aspect of the 
abdomen on each side of the vertebra. The upper pole of each kidney lies opposite 
the  T 12 vertebra, and the lower pole lies opposite to the L3 vertebra. The right 
kidney is usually more caudal in position. The weight of each kidney measures 125 
g to 170 g in the male and from 115 g to 155 g in the female. The human kidney is 
about  11 cm to 12 cm in length, 5.0 cm to 7.5 cm in width, and 2.5 cm to 3.0 cm 
in antero posterior diameter . On the medial surface of each kidney is the hilus, 
through which the renal pelvis, the renal artery and vein, the lymphatics, and a 
nerve plexus pass into the sinus of the kidney. 
The renal artery enters the hilar region and it divides to form an anterior and 
a posterior branch. The anterior branch divides into three segmental arteries  and 
supply the upper, middle, and lower thirds of the anterior surface of the kidney . 
The posterior branch of renal artery supplies the posterior surface and occasionally 
gives rise to a small apical segmental branch. There are no collateral circulation 
between the  segmental or lobar arteries or  their subdivisions. 
            The kidney has two distinct regions , a pale outer region, the cortex, and a 
darker inner region, the  medulla . The medulla has 8 to 18 striated conical masses 
called the renal pyramids. The base of the pyramid is located at the 
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corticomedullary junction , and the apex is toward the renal pelvis and it forms the 
papilla. On the tip of each papilla there are 15 to 20 small openings .They are  the 
distal ends of the  collecting ducts .     
The medulla is divided into an inner and an outer zone, with the outer zone 
subdivided into an inner and an outer stripe . The inner medulla contains both 
descending and ascending thin limbs of loop of henle and large collecting ducts, 
including the ducts of Bellini. In the inner stripe of the outer medulla, thick 
ascending limbs are present in addition to descending thin limbs and collecting 
ducts. The outer stripe of the outer medulla contains the terminal segments of the 
pars recta of the proximal tubule, the thick ascending  limbs (partes rectae of the 
distal tubule), and collecting ducts. The division of the kidney into cortical and 
medullary zones and the further subdivision of the medulla into inner and outer 
zones is of great importance in relating kidney to the ability to form a maximally 
concentrated urine.  
BENIGN RENAL LESIONS 
Renal cysts 
Renal cysts are the most common benign lesions of the kidney. They 
account for more than 65% of   renal masses. They are usually asymptomatic. They 
can be either solitary, multiple and bilateral. The Bosniak classification for renal 
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cysts, is the most often used method for characterizing renal cysts and for 
determining the likelihood of the presence of associated malignancy within the 
cyst. There is an increased risk of malignancy in Bosniak class III and IV and 
hence therapy is  recommended. 
ANGIOMYOLIPOMA 
Angiomyolipoma constitutes  about 8% of the renal tumors. It is a benign 
tumor that consists of vessels, smooth muscle,mature adipose tissue. It may be 
either sporadic or familial.The usual mode of a sporadic presentation is of a 
middle-aged female with a single asymptomatic tumor. Usually they grow slow 
and are detected incidentally. It  is the most common renal mass lesion that is 
associated with spontaneous perirenal hemorrhage, the next being RCC.AML is 
usually associated with tuberous sclerosis in 20 to 30 percent of patients. The 
presence of fat  −20 Hounsfield Units  is considered  diagnostic of AML. The 
differential diagnosis include liposarcoma, fat containing RCC, and fat poor 
angiomyolipoma resembling an RCC. The treatment  of AML depends on the size, 
symptoms  and patient factors. Lesions  less than 4 cm are usually managed 
conservatively with repeat scan at 6 to 12 months. Surgery should be reserved for 
those symptomatic , age, comorbid conditions and in women of childbearing age . 
In tuberous sclerosis or in multiple tumors nephron sparing surgery should be 
done. 
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CYSTIC NEPHROMA 
Cystic nephroma  has bimodal age distribution and usually it occurs in  first 
2 to 3 years of life, males, and also in  fifth decade. The male to female ratio is 1:8. 
The symptoms are  abdominal mass, pain, and hematuria, but cystic nephromas are 
usually diagnosed incidentally.They are solitary, centrally located, showing 
curvilinear calcifications, and herniation into the pelvi calyceal system, and septal 
enhancement .So the  radiologic differentiation between cystic nephroma 
and cystic RCC is difficult. They  are well encapsulated, and has a fibrous 
pseudocapsule. It has cysts lined by flattened, cuboidal epithelium.IHC shows 
positive for CD10,calretinin, inhibin, estrogen, and progesterone receptors .In 
children where there is a doubt in the diagnosis of wilms tumor, nephrectomy is 
done. 
ONCOCYTOMA 
This  benign renal tumor  is clinically and radiographically indistinguishable 
from RCC. There is a higher incidence of oncocytoma in elderly patients with a 
small renal mass as compared to younger patients. They originate from the distal 
tubules, which is similar to chromophobe RCC. This may represent as a spectrum 
of disease as evidenced in Birt-Hogg-Dubé genetic syndrome, but there is no study 
that states that oncocytomas transform into malignant transformation in sporadic 
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cases. If oncocytoma is suspected , a percutaneous core biopsy may reliably 
provide a diagnosis. Frozen section during surgery does not distinguish the 
oncocytoma from RCC and this should not be done to plan the treatment strategy. 
METANEPHRIC ADENOMA 
Metanephric adenoma is a recently described, rare benign mass that is not 
differentiated from RCC radiologically. It is usually found incidentally, and 
predominantly occurs in females. It occurs in the fifth decade . The diagnosis is 
done after surgical excision and can be confirmed with IHC for cytokeratins,WT1, 
S-100, and AMACR.   
RISK FACTORS - RCC 
RCCs arises from the proximal convoluted tubules  and the most common 
histologic subtypes that arise from them are  clear cell ca and papillary RCC. But 
the newer studies states that the chromophobe and collecting duct RCC, the other 
less common types, are usually derived from the more distal components of the 
nephron . 
           The most important risk factor for Renal Cell Carcinoma is tobacco 
exposure. The relative risk of RCC with the use of tobacco has been modest which 
ranges from 1.4 to 2.5 when compared with that of controls. The risk of RCC has 
been implicated with the use of tobacco of all forms and the risk increases with 
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increasing  dose of tobacco or pack-years .Relative risk  of RCC is directly 
proportional to the duration of smoking and the number of  smokes per day and  
the risk begins to fall after stopping tobacco use, further supporting a cause and 
effect relationship .   
The next major risk factor for RCC is Obesity.  For each unit of increasing  
body mass index , there is an increase in the relative risk by 1.07.  In Western 
countries where there is  increased prevalence of obesity there is an increased 
incidence of RCC .Recent estimates from the united states shows that about one 
third of the RCC has an increased body mass index. Potential mechanisms that 
links obesity to RCC  are numerous. Lipid peroxidation  leading to the damages in 
DNA , increased expression of insulin-like growth factor-1, increased circulating 
levels of estrogen, and increased arteriosclerosis in the renal tissue  and local 
inflammation  are the mechanisms for the development of RCC in obesity. 
Hypertension is an important factor  for the development of RCC. Diuretics 
are also thought of as a significant risk factor in RCC but further evidence suggests 
that the drug is not the factor and the disease is the cause. The proposed 
mechanisms for the development of  RCC  are that  Hypertension produces renal 
injury and it also causes inflammation associated with  metabolic or functional 
changes in the nephron tubules that may increase susceptibility to carcinogens . 
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Viruses , lead compounds and benzene compounds are  risk factors in others 
where  there are no studies that say that these above mentioned factors are a risk 
factor for RCC. Chloroform exposure as once thought in the risk factor group was 
not so as there are many bias in the studies conducted.But the VHL gene is 
mutated when there is a chloroform exposure.Workers from asbestos or cadmium 
industries are at relatively increased risk of RCC. 
There are many  Case control studies that has  shown that Renal cell 
carcinoma is more common in poor economic status and city population but the 
relationship for the risk of RCC has not been told in the study. The  Western diet 
which typically includes a high fat,high protein, and low fruits and vegetables, or 
when there is  increased intake of dairy products, and increased consumption of 
coffee or tea have been associated with  increased risk of RCC, but the relative risk 
is only  modest, and the data is conflicting  in most instances . A family history of  
RCC is  also a  risk factor for RCC. One  study reports  a relative risk of  2.9 for 
persons with a first- or second-degree relative with RCC . 
Thorotrast ( a contrast agent ), and radiation therapy for malignancy is also a 
risk factor for RCC.The   relative risks are low  for the above reported  causes.But 
only few cases of RCC developed in post testicular ca radiation therapy or post 
wilms tumor radiation therapy.  There is an increased incidence of RCC that is also 
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seen  in patients with chronic kidney disease and in patients with tuberous 
sclerosis. 
PATHOGENESIS 
  Renal cell carcinoma arises from the proximal convoluted tubule and it 
comprises of  90% of the kidney tumour in adults. RCC has diverse clinical, 
pathological, and molecular characteristics and hence there are distinct prognosis 
and therapeutic responses  between those groups.  
PATHOLOGICAL CLASSIFICATION OF RCC  
The pathological classification of RCC is providing relevant prognostic 
information and guidance to therapy. As the development of molecular 
mechanisms of renal tumors has been strongly elucidated, molecular classification 
is to be eventually replaced by morphological classification in the near future. 
Histologic  Subtypes  of Renal Cell Carcinoma 
 CLEAR CELL RCC 
Clinical Features  
  Clear cell RCC is the most common subtype and  it accounts for 70% of all 
RCCs. It is most common in the sixth to Seventh decade. The  males to 
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female ratio is approximately 2:1 .Clear cell RCC is usually sporadic and 
only 2-4% are familial. 
Familial cases occur at a younger age and they are most likely to be multifocal and 
bilateral. 
Pathology  
Clear cell RCC is usually unilateral and unicentric. It is round and appears as 
a exophytic mass with a fibrous capsule. It has a golden yellow colour and 
variegated appearance with different degrees of hemorrhage, necrosis,and 
calcification
6
 .  Microscopically the tumor cells are arranged in sheets,alveolar, or 
acinar structures . They  have clear cytoplasm due to tissue processing and the loss 
of  glycogen and lipid. 
  
 Clear cell RCC 
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Molecular Genetics  
Clear Cell RCCs has chromosome 3p mutations which includes deletion, mutation, 
or methylation  in the  von Hippel–Lindau ( VHL) gene on chromosome 3p25-26. 
Somatic mutations in VHL gene has been found in 18–82% of sporadic RCC 
The heterozygosity loss in the VHL locus is seen in 98% of cases. 
Hypermethylation of the VHLgene is seen in 5–20% of patients. Others show   
 allelic loss or LOH at the VHL locus, which is the Knudson’s two-hit model of 
malignant transformation.The VHL regulates the  Hypoxia-inducible factor (HIF) . 
Consequently, HIF levels stimulates VEGF, PDGF, TGF- a , CA IX.Also the PI3 
kinase ,mTOR pathway and Ras-raf pathway are activated which are involved in 
cell proliferation and survival. These pathways produce angiogenesis and prevent 
apoptosis and better survival of cells under hypoxic conditions. 
PAPILLARY RCC 
CLINICAL FEATURES  
Papillary RCC is the next most common type of RCC and it comprises of 
10–15% of RCCs. Papillary RCC is a better prognostic tumor. Most of them occur 
sporadically, but hereditary Papillary RCC are also seen.  
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Pathology  
Papillary RCC presents as a well circumscribed mass which has a 
pseudocapsule
7
. Few tumors are necrotic and friable. Papillary RCC are usually 
bilateral and multifocal . Microscopically, Papillary RCC has different  proportions 
of papillae, tubulopapillae, and tubules. The  papillae has fibrovascular cores with 
foamy histiocytes.Two subtypes of Papillary RCC are present depending upon  the 
histology. The  Type I tumor which accounts for two thirds of cases contains short 
papillae  with single layer of  cells, scant cytoplasm and low-grade nuclei . On the 
other hand the Type II tumor has large papillae and cells with abundant 
eosinophilic cytoplasm,large pseudostratified nuclei and  prominent nucleoli .Type 
II tumors have poor prognosis when compared to the former.  
 
  
TYPE I PAPILLARY RCC                         TYPE II PAPILLARY RCC 
15 
 
Molecular Genetics  
Trisomy 7,  17, and loss of Y chromosome  is the most common finding in 
Papilllary RCC. Gain of 7p and 17p is seen  in type I tumors  . 9p deletion is 
present in  20% of PRCC and loss of heterozygosity at 9p13is present in type II 
tumors. 
CHROMOPHOBE RCC  
CLINICAL FEATURES  
Chromophobe RCC constitutes  5% of RCCs and it arises from the intercalated 
cells of the collecting ducts  . Chromophobe RCC age range is in the fifth decade. 
Males and females are affected equally. It has better prognosis than Clear Cell 
RCC. 
 Pathology  
Chromophobe RCC appears as a solitary, well-circumscribed mass that is  
nonencapsulated and it is  homogenous ,light brown in colour on cut surface
8
. 
Hemorrhage, necrosis is uncommon.Microscopically, the cells are arranged in 
solid sheets,which are  large and polygonal . They  have  fine reticulated cytoplasm 
which is due to cytoplasmic microvesicles. 
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CHROMOPHOBE  RCC 
The nuclei are hyperchromatic and irregular with perinuclear halos , which has a 
plant cell like appearance. The tumor has  intensely eosinophilic cytoplasm, termed  
eosinophilic variant .  
Molecular Genetics  
Chromophobe RCC has  loss of  chromosome Y, 1, 2,6, 10,13, 17, and 21 . 
It can occur in BHD syndrome, with mutations in Birt Hogg Dube gene ( BHD)  
17p11.2, which encodes the protein folliculin  .But sporadic chromophobe RCC 
has rare mutations in the BHD gene. 
RENAL CELL CARCINOMA, UNCLASSIFIED TYPE  
Unclassified type, is the term used when the histological type  does not fit 
into any of the decribed histological varieties. This is a not a true biological entity 
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but a diagnostic category. These are a heterogeneous group of malignancies with 
poorly defined clinical, morphological, or genetic features. RCC subtypes with 
sarcomatoid morphology without recognizable epithelial elements, mucin 
production, mixtures of epithelial and stromal elements and unrecognizable cell 
types
 
are included.These tumors are poorly differentiated and have a poor 
prognosis.In published series the assignment to this category varies from 0.7% to 
5.7% 
COLLECTING DUCT CARCINOMA 
This is a rare subtype of RCC which constitutes 0.4  to 1.8 % of  RCC. 
These tumors are highly aggressive and presents at an advanced age with poor 
prognosis. This occurs at a wide patient age range with male predominance of 2:1 
.These are large with firm white to gray appearance with irregular borders and 
areas of  necrosis. Histology shows a infiltrative tubular or tubulopapillary pattern. 
It has dense desmoplastic reaction with higher nuclear grade. The molecular 
pathway is poorly understood. Monosomy of chromosome 1,6,4,15 and 22 with 
allelic loss of chromosomal arms 1q ,6p,8p 13q and 21q are reported. Two thirds of 
collecting duct RCC has a minimal deletion in 1q 32.1 region. 
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                                COLLECTING DUCT CARCINOMA 
PATHOLOGICAL PROGNOSITIC PARAMETERS FOR RENAL CELL 
CARCINOMA  
Fuhrman Nuclear Grading  
Fuhrman grading was  first described in 1982.It is the most commonly used 
grading system for RCC. It depends on the nuclear size and shape, chromatin and 
nucleolar prominence. It  is categorized into G1–G4.It  is an independent 
prognostic predictor for RCC . Grade 1 and  2 may be taken together as low grade 
because they are not behaving different in terms of prognosis  in multivariate 
analysis. But grade 3 and grade 4 tumors must not be grouped together because the 
former have better 5-year cancer-specific survival than the later. 
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GRADE NUCLEAR 
SIZE µM 
 NUCLEAR 
SHAPE 
CHROMATIN  NUCLEOLI 
1 < 10 ROUND DENSE NOT VISIBLE 
2 10-15 ROUND FINE GRANULAR SMALL 
3 15-20 ROUND/OVAL COARSE 
GRANULAR 
PROMINENT 
4 >20 PLEOMORPHIC HYPERCHROMATIC LARGE 
 
The 5 year CSS for grade III and grade IV are 45–65% and 25–40%  
respectively.The prognostic value of Fuhrman grading for nonclear cell RCC, 
however, remains controversial.There is no statistical significance for papillary ca 
in multivariate analysis.Of all the parameters the nucleolar features gain 
importance.It is associated with survival in both univariate and multivariate 
analyses.  
.              FUHRMAN GRADE I           
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FUHRMAN GRADE II 
  FUHRMAN GRADE III
 FUHRMAN GRADE IV 
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Sarcomatoid Differentiation  
Sarcomatoid differentiation is present in about 5% of RCCs and can be 
observed in any RCC subtype . So the  sarcomatoid RCC is now not considered a 
distinct subtype of RCC by 2004 WHO classification. It is a presentation of a high-
grade and poorly differentiated component. RCC with sarcomatoid differentiation 
typically will have other adverse features, which include large tumor size,  
perinephric fat and vessels extension, and presence of hemorrhage and necrosis. 
The patients usually present with distant metastasis and there is an increased risk of 
cancer-specific death. It is a poor prognostic indicator in univariate and 
multivariate analyses .Usually this sarcomatoid differentiation is given a Fuhrman 
grade 4 by the pathologists. Sarcomatoid components will appear as bulging, 
lobulated areas with white to gray and it has a firm and fibrous cut surface .  
 
         SARCOMATOID DIFFERENTIATION 
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Histologically, there are malignant spindle cells with resemblance to 
leiomyosarcoma, fibrosarcoma, angiosarcoma, rhabdomyosarcoma. So the existing 
RCC which may be clear cell, papillary, chromophobe RCC  and sometimes 
collecting duct RCC are mentioned  with sarcomatoid differentiation. However, if 
any of the  subtypes could not be possible and  if the sarcomatoid component 
overruns RCC epithelial components,which is a rare occurrence, then the 
possibility of a primary sarcomatoid carcinoma arises. Rhabdoid differentiation is 
in approximately 5% of RCCs with large eccentric nuclei, macronucleoli and 
prominent acidophilic globular cytoplasm . It is  associated with high grade and 
stage with extrarenal extension. It is a marker of high risk for metastasis and 
adverse prognosis even when the rhabdoid component is minimal  .  
Tumor Necrosis  
  In Clear Cell RCC ,when tumor necrosis is  identified  macroscopically or 
microscopically,it  is a poor  pathological factor and is associated with adverse 
clinical outcomes in both univariate and multivariate analysis.  Mayo Clinic study 
clearly depicts  that histological necrosis is associated with twice the CS Death rate 
compared to those without necrosis .  Two nomograms  ,SSIGN from Mayo Clinic, 
and  nomogram from MSKCC, both incorporate tumor necrosis  . The extent of 
necrosis has a good correlation with the cancer specific death rates.In non clear cell 
RCC the role of tumor necrosis in  prognostication is limited. 
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Microvascular Invasion  
Microvascular invasion is defined as tumor  cells invading the vessel wall or 
neoplastic emboli in the intra tumoral vessel detected microscopically. This is  
present in 13.6–44.6% of RCC. RCC of high stage and grade usually have 
microvascular invasion. The prognostic role in RCC is controversial. But there are  
several studies that demonstrate that MVI may have an independent predictive role 
for cancer-specific mortality or disease recurrence. 
Imaging 
PLAIN RADIOGRAPHY 
Plain radiographs are the imaging techniques before the era of  ultrasound or 
computed tomography (CT) or MRI. Usually RCC is not seen on a plain x ray but 
on rare occasions it may be seen .It appears as an  space occupying lesion that is 
irregular.It  distorts the normal appearance of the renal shadow.15% of RCC has 
calcifications which can be identified on a plain X ray KUB. The calcification  can 
be thin peripheral rim calcification or irregular central calcification, or it can be a 
combination. When there is a calcification in the periphery which appears thin then 
the probable diagnosis  are  80% benign cysts, 20% cystic renal malignancies. On 
the other hand the renal masses which are containing central, irregular calcification 
are the ones which are malignant (87% ). A calcification in both the centre and the 
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periphery of a renal mass makes the proabablity of renal mass to be malignant by 
50%.  
Lytic skeletal abnormalities which are due to hematogenous spread can be 
seen. When the growth of the lesion is slow and when there is a bubbly appearance 
on a X ray , there are more chances of malignancy due to the metastasis.Plain X 
ray of the skull and the spine should be taken in case of RCC associated with 
Tuberous sclerosis because of the associated Skull and spine osteomas. 
 INTRAVENOUS UROGRAPHY 
Intravenous urography (IVU) is used to investigate the nature of a renal 
mass lesion and the proportion of  normal functioning segment of the uninvolved 
kidney. Nowadays when investigations such as CT and MRI are available, IVU is 
becoming less popular.IVU is usually performed in the following way. A scout 
abdominal or KUB radiograph is first taken and then 40 mL of contrast 
administration over 30 s. Any calcification is to be looked for in the pilot film and 
the bowel gas should be noted before the contrast administration.  
RCC is an expansile and an exophytic mass that alters the  normal contour 
and it displaces the normal renal structures. RCC produces calyceal splaying and 
stretching ,with destruction of the calyces.Occasionally, an exophytic RCC can 
cause no effect on the calyceal system. When RCCs are located in a direction that 
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is above or below the  kidney there may  be a hinderance  to locate the lesion with 
IVU, because the lesion can be masked by the overlying pelvicalyceal system and 
the nephrogram from the normal kidney. Other supportive evidence that can be 
seen in a IVU that are diagnostic of RCC is the pelvic notching .It occurs due to 
enlarged pelvic vessels  at the pelvi uretric junction where there is an increased 
blood supply to a RCC.  
ULTRASOUND 
The Renal ultrasound with Doppler is the cost effective modality and most 
of the renal masses are easily picked up by an ultrasound abdomen imaging .The 
ultrasound has the ability to differentiate  whether the content is solid or fluid  and 
hence when the diagnosis of the renal masses are made  as simple cysts there will 
be no further diagnostic evaluation .Echogenicity, vascularity , invasion into 
adjacent structures and calcification are the features that are to be looked for in an 
ultrasound examination. On ultrasound, RCCs are seen as a single or multifocal 
mass that are exophytic but they are not diagnostic. These masses may be either 
hypoechoic, isoechoic, or hyperechoic when compared with that of the normal 
renal parenchyma.When there are heterogenous  echoes in a cystic lesion a 
diagnosis of RCC should be suspected. 
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About  33 % of RCCs are hyperechoic , but  when size of an RCC is small  
and it is not a classical hyperehogenicity on Ultrasound, a diagnosis of  
angiomyolipoma  should be made and proceeded with definitive investigations. 
When there is a mass with an anechoic perimeter or  cystic areas internally ,on 
USG examination, they suggest RCC, and  a CT or MRI is  further required for 
evaluation.RCC has intra tumoral fat when there is a tumor encasement of the 
perirenal or renal sinus fat. Ultrasound has the ability to show the internal 
architecture of renal tumors. This feature is very useful when lesions which are  
equivocal (neither the lesion is benign or purely malignant) on CT or MRI .It may 
demonstrate the septa and can say whether  there are solid elements in the 
periphery of the renal mass lesion so that when these features are present a 
diagnosis of a malignancy can be done with a probability. Ultrasound is used to 
detect  the features that are due to the infiltration of the surrounding structures by 
RCC such as hydronephrosis . When there is an encasement of the renal vessels by  
RCC there is  diminished blood flow to the area that is involved and that can be 
picked up by a Doppler scan. An RCC that is infiltrating sometimes ,may cause 
only minimal  abnormalities or none . Doppler examination is a specific test to 
look for the renal vein thrombus and IVC thrombus but the extent of thrombus 
should be made by MRI/Echocardiogram or a transesophageal echo. Staging of  
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RCC and hilar lymphadenopathy detection is limited by the ultrasound 
examination.  
COMPUTED TOMOGRAPHY 
A thin slice CECT scan is the most important diagnostic test used in the 
diagnosis of a renal mass .A renal mass that enhances by more than 15 HU after 
the contrast administration is to be considered an RCC until proved otherwise. 
Solid mass lesions with attenuation of less than – 20 HU are due to the presence of 
fat and are diagnostic of angiomyolipoma .The new technique of multidetector row 
computed tomography (MDCT)  allows the formation of high quality images with 
a good resolution and also the scanning time is much more faster , and  multiphase 
images are taken. The data getting times is usually very short with the MDCT 
because they have short gantry rotation time usually 0.5 seconds.It is usually 
combined with many detectors so that it provides increased coverage along the z 
axis. Retrospectively, with this MDCT, different multiplanar images and 3D 
format imaging with minimal artifacts can be done this is made possible by very 
small section data reconstruction with anusual isotropic data is also obtained. So 
the total kidney can be imaged in less than 10 seconds . Renal vasculature imaging 
and collecting system imaging can be done with the help of this multiphase 
imaging. This is most important when a nephron sparing surgery is planned. 
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The precontrast image in a CT  scan is also important because by this, a 
diagnosis of a hyperdense cyst can be made. Corticomedullary images gives 
greater detail in  the assessment of renal vessels, tumor vascularity, and the 
involvement of the venous system by the lesion. In the corticomedullary phase 
contrast is present in the small blood vessels in the cortical region , the cells 
surrounding the tubules, proximal  tubules, and in the columns of Bertin. So the 
correct time of the corticomedullary phase depends on the speed and volume of  
contrast that is injected, and the patient’s heart rate and the cardiac output. The 
next phase is the nephrographic phase . It occurs when the contrast moves further 
down the tubules.It is during this phase, there is  homogeneous enhancement in the 
kidney. Here the lesions that are situated in the medulla also enhance well. So this 
phase is the best phase for the identification  of small renal masses .  
The next phase is the excretory phase which begins when the contrast is 
secreted into the pelvicalyceal system, approximately 5 min after contrast 
administration.In this phase, the nephrogram is still  homogeneous but its 
measurements in terms of HU is minimised. When the mass is located 
centrifugally,and when there is an involvement of the pelvicalyceal system the 
image should be taken in this phase for better diagnosis.  
There are some pitfalls in the measurement of HU in the CT scan. Due to 
feature called beam hardening, the HU can move slightly above the normal value 
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because of the contrast enhancement in the normal renal tissue that is located 
nearby. This increase in the value is more pronounced when the lesions are small 
,that are located intrarenally.  
Although minimal areas of enhancement can be taken into consideration for 
the diagnosis, the lesions with no definitive change after contrast or if there is a 
change in HU by less than 20 HU it should be considered as an indeterminate mass 
and further evaluation with  MRI must be done.So in small lesions MRI has to be 
used for equivocal contrast enhancement. The  time taken for the persistence of 
contrast enhancement in case of renal masses is minimal.So the washout time from 
the mass can be  studied by the use of an MRI. A study has suggested that the 
measurement of the washout of contrast  from the mass at 15 min shows the ability  
to differentiate between  renal neoplasms and hyperdense cysts.  
MAGNETIC RESONANCE IMAGING 
The most peculiar feature and the most advantageous  one with MRI over 
other imaging modalities is that it produces good images of the soft tissue and 
scanning can be done in the axial, coronal and the sagittal sections. With the use of 
MRI, the T staging in the malignant renal masses are made and therby appropriate 
management can be planned. When the use of contrast has been contraindicated in 
case of chronic renal failure or contrast allergy,MRI is the test that is useful 
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.Patients who have a solitary functioning kidney and those who need repeated CT 
to be done for follow up, can be followed up with MRI. This benefits the patient 
both from the effects of radiation and the dose of contrast that is frequently used 
which may precipitate renal failure in these patients. 
The MRI scan should be taken by asking the patients to hold their 
breath.Nowadays respiration gated MRI have also come into vogue that are more 
breath friendly. The following sequence of images are taken (a) a T1 image with in 
and out of phase.This is helpful for the detection of fat because there will be signal 
loss in out of phase images (b) T2-weighted image in axial or coronal planes.This 
best gives the anatomy of the renal mass, the relationship of the mass to the renal 
pelvicalyceal system and the features of the mass that are probably malignant (3) a 
dynamic contrast enhanced T1 image. 
For the contrast pictures, the pictures are usually obtained before and after 
contrast administration during the arterial, corticomedullary, and nephrographic 
phases. As mentioned previously, on all these phases, the nature of the mass can be 
studied.Multiple thin slices of films should be taken and that too the images are to 
be taken in the saggital and coronal views so that they give a better idea about the 
location of the mass to the collecting system and the adjacent retroperitoneal 
structures. If a nephron sparing surgery is planned then the pictures are to be taken 
in an arterial phase so that the normal renal tissue supplied by the vessels should be 
31 
 
identified and that should be spared. During the phase of contrast excretion from 
the collecting system, the pictures should be taken in the coronal plane to obtain 
the whole urogram view. It is during this excretory phase the presence of  venous 
thrombi can be seen. 
RCC is  usually seen as hypointense or isointense  on  T1-weighted images. 
They are heterogeneously hyperintense on T2-weighted images. RCC readily 
enhances with contrast  gadolinium. The above mentioned clauses have exception 
and they may be of any intensity. The enhancement of a renal mass is less than that 
of the normal renal parenchyma and it should be looked in  T 1 images. When 
there is a small amount of fat in  RCC there  will be signal loss when out of phase 
images are obtained. So whenever there is a signal loss in an RCC there should not 
be a hurry in the diagnosis of an AML. The fat in RCC may be due to the osseous 
metaplasia or due to the engulfment of the renal sinus fat by the tumor. When there 
is an irregular thickening in the wall of a cystic lesion or nodules or when there is 
an enhancement there is a suspicion that the mass is malignant. 
DIFFUSSION WEIGHTED MRI 
Brownian motion or the movement of the water molecules forms the basis of 
the diffusion weighted MRI. It is the restriction to the movement of protons in the 
water molecules.This depends on the environment ,where the protons are situated 
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in the renal masses, which are both qualitatively and quantitatively assesed.In 
tumors which are highly cellular and which has higher density of cell membranes 
there is restricted motions of proton molecules.This restricted motion of protons is 
seen as high signal intensity on DWI images with a corresponding low apparent 
diffusion coeffiecient value (ADC) , which measures the quantitative value of the 
MR imaging.DWI  is used in clinical practice by measuring the signal intensity and 
the ADC value of the normal renal parenchyma and the lesions.Quantitative values 
are being examined by several researchers for distinguishing between the benign 
and malignant character of the renal neoplasms. 
Diffusion-weighted imaging (DWI) is most commonly used in brain.Initial 
studies  that has been conducted had shown great accuracy in the depiction of 
lesions as cerebral stroke,  malinancy,  diseases due to bacteria and viruses  and 
metabolic  conditions .Due to the  inherent extreme sensitivity to motion which is 
from breathing and bowel movements  and artefacts, which results  in a high signal 
to noise ratio , the role of DWI  is limited to the cranial cavity.But because of the 
advances in  MR imaging and the use of quick  sequences in MRI good quality 
images  is being  obtained in abdominal imaging .  
The management for the RCC should be appropriate and hence it is 
important to diagnose that the mass is actually benign or malignant.So there is a 
need for the ADC values in case of a renal mass  so as to make a diagnosis when 
33 
 
the contrast cannot be administered and in case of indeterminate mass.The  ADC 
value  was high  in simple renal cysts and renal pelvis of hydronephrotic kidney 
because of the high levels of diffusion .In case of malignancy ,where there is a low 
level of diffusion, there will be low ADC value. Cellular lesions such as RCC will 
have higher b value when compared with normal renal parenchyma.So in diffusion 
weighted imaging, the ADC values are compared using  b values of 0,400,800.  
The role of the ADC value in characterising the histological subtypes of 
renal carcinoma is limited in previous studies. It will also differentiate the grade of 
the tumours as the high grade tumours will show restricted diffusion.  Therefore, 
the present study aimed to evaluate the role of DWI in combination with T 1 and T 
2 weighted MRI for the  characterisation of renal carcinoma. 
 
A MRI of a right renal mass 
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 Diffusion weighted MRI mass showing restricted diffusion with increased signal 
intensity and low ADC value. 
                             
 
 
 
35 
 
  
                                           MATERIALS AND METHODS 
 
STUDY DESIGN 
Prospective cross-sectional diagnostic study  
PLACE OF STUDY 
The study was conducted in the Department of Urology, Madras Medical College 
and Rajiv Gandhi Government Hospital, Chennai- 3. 
ETHICAL CLEARANCE 
The institutional ethical review board at our hospital approved the study. 
(No 10062013) 
INCLUSION CRITERIA 
All newly diagnosed cases of renal masses 
EXCLUSION CRITERIA 
1. Patients  with Renal masses less than 2 cm.  
2. Previously received chemotherapy or radiotherapy for renal masses. 
3. Prior diagnosis of TCC pelvis.              
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METHOD OF STUDY 
Informed consent obtained from all the patients after explaining details of the 
study. All details were recorded in a proforma as an inpatient procedure. Analysis 
was done with the collected details prospectively. 
PATIENT EVALUATION 
     All cases of renal masses will be evaluated by clinical examination, renal 
function tests, S.calcium ,E.S.R ,Complete haemogram,LFT, CXR ,imaging studies 
in the form of USG with Doppler / CECT KUB.  
MRI  
MR Imaging 
MR imaging was performed with  1.5-T clinical MR systems (Magnetom  Siemens 
Medical Solutions,  Germany) by using  body phased-array coils  using eight 
elements . The routine renal mass MR imaging protocol included the use of getting 
the images in T1 in and out of phase using respiration gated techniques.A second  
coronal T2 image  breath hold half  Fourier single shot turbo spin echo sequence 
was taken.Three different  breath-hold DW image acquisitions was performed in 
the transverse plane by using a fat suppressed single shot echo planar imaging 
sequence with tridirectional gradients and three sets of b values: 0, 400, and 800 
sec/mm 2 .  
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ADC CALCULATIONS  
 ADC mapping  is done  at the console of the MRI . With  linear regression 
analysis  of function , the ADC  value was calculated. All renal masses with a 
maximal size more than 2 cm  were  precisely characterised on basis of signal 
intensity on T1- and T2-weighted images and image subtraction . Cystic renal 
lesions are classified  according to the Bosniak classification system . Fat-
containing AMLs were diagnosed by the standard  criteria based on findings at in  
phase and out of phase T1 weighted imaging. Hence  renal lesions were diagnosed 
to be  benign  or presumably  malignant . 
                                      The mean ADC values of the lesions found on MRI  were 
measured by using regions of interest . An average of two or three measurements 
per lesion is done , which depends upon  on the size of the lesion. The regions 
measured has a mean size of about 4 cm that were round or oval, depending on the 
size of the lesion. In all patients, the region of interest included the entire lesion 
and we left the necrotic area of the renal mass. 
                         The  ADC values  of the normal kidney in the both the renal cortex 
and the medulla were measured in three locations (upper, middle,and lower poles)  
of the kidney (one kidney in cases of prior nephrectomy) .  The  measured regions 
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of interest were about  1–2 cm in diameter, and measurements from all patients 
were taken and the mean was found out. 
                                             All malignant and benign lesions  were confirmed at 
histopathologic examination after partial or total nephrectomy. Diffusion weighted 
Magnetic Resonance Imaging of  KUBU region will be taken at the time of 
hospital admission. The tumor ADC Values and the values from the kidney was 
noted. The patients are taken up for radical/simple nephrectomy. These results will 
be correlated with Clinical, Imaging and the pathological finding. 
STUDY ANALYSIS 
The Statistical Package for the Social Sciences, version 18.0.2 (SPSS ) was used 
for the statistical analysis. A p value equal  to or below 0.05 was considered 
significant. 
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                                                     RESULTS 
   Our study consists of about 44 patients of which four did not meet the inclusion 
criteria. One pt was morbidly ill, so a histopathological examination could not be 
obtained . Two cases of TCC pelvis were diagnosed preoperatively and were 
excluded in the study. In one case, the size of the renal mass lesion was 2 cm and 
was excluded from the study as the patient opted for active surveillance. 
 
TOTAL – 44 PTS 
 
 
 
 2 PTS –TCC ,1 MORBID ILL, 1- ACTIVE SURVILENCE 
 
 
 
40 PTS - STUDY 
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                                    PATIENTS CHARACTERSTICS 
GENDER DISTRIBUTION IN THE STUDY POPULATION 
 
There were twenty males and twenty females in the study population. 
Equally distributed of about 50% in the study. 
                                       AGE DISTRIBUTION 
 N Minimum Maximum Mean Std. Deviation 
Age in years 40 35 81 53.98 10.726 
          
      
 
  
NUMBER 
MALE
FEMALE
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DIFFUSION WEIGHTED MRI IMAGES OF PATIENTS WITH RENAL 
MASSES 
                      
                Right renal mass with DWI . ADC VALUE – 1.32 x 10-3MM2/S  
                    
                  RIGHT  RENAL MASS DWI .ADC VALUE – 1.64 x 10-3MM2/S 
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                                    HISTOPATHOLOGY REPORTS 
 
 
From the 40 nephrectomised specimens ,the clear cell RCC cases were about 20 , 
non clear cell RCC  were 10 and benign pathology were 10. 
 
Of the thirty cases of malignancy, 3 cases were T1 and 8 cases were  stage T2 and  
19 cases in stage T3. The mean size of the renal masses were  11.56 cm . 
20 
10 10 
40 
0
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                        MEAN ADC VALUE OF THE RENAL MASSES 
 
 N Mean S.D 
Std. 
Error 
95% Confidence Interval 
for Mean Min Max 
          Lower Bound 
Upper 
Bound     
CC 
RCC 
20 1.2765 .09511 .02127 1.2320 1.3210 1.12 1.44 
Non CC 
RCC 
10 1.6880 .08651 .02736 1.6261 1.7499 1.53 1.81 
Benign 
10 2.4260 .43257 .13679 2.1166 2.7354 1.68 2.84 
Total 
40 1.6667 .52473 .08297 1.4989 1.8346 1.12 2.84 
 
The  mean ADC value of the clear cell RCC group is 1.27 X 10
-3
mm
2
/s. 
The mean ADC value of the Non Clear cell RCC  is 1.68 X 10
-3
mm
2
/s. 
The mean ADC value of the benign renal masses in our study is 2.42X 10
-3
mm
2
/s. 
So the cut off ADC value for diagnosing all malignant vs benign lesions would be 
less than 1.74X 10
-3
mm
2
/s.and the ADC value for diagnosing clear cell vs non 
clear cell lesions would be  1.32 X 10
-3
mm
2
/s  ( using 95 % confidence limits) 
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    COMPARISION OF ADC VALUE BETWEEN THE GROUPS 
(I) HPE 
Report 
(J) HPE 
Report 
Mean 
Differen
ce (I-J) 
Std. 
Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
CC RCC Non CC 
RCC 
-.4115(*) .08830 .001 -.6271 -.1959 
Benign -
1.1495(*
) 
.08830 .001 -1.3651 -.9339 
Non CC 
RCC 
CC RCC 
.4115(*) .08830 .001 .1959 .6271 
  Benign -.7380(*) .10196 .001 -.9869 -.4891 
Benign CC RCC 1.1495(*
) 
.08830 .001 .9339 1.3651 
  Non CC 
RCC 
.7380(*) .10196 .001 .4891 .9869 
 
The mean values compared between the other groups that is between the malignant 
and the benign and the clear cell and the non clear cell group are statistically 
significant. 
Comparison of histological grades between the clear cell RCC groups 
The mean ADC value  cut off  for diagnosing a high grade RCC is 
1.23 X 10
-3
mm
2
/s.( 95 % confidence limits) 
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COMPARISION OF ADC VALUE BETWEEN THE CLEAR CELL RCC 
GRADES 
 N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimu
m 
Maxim
um 
          
Lower 
Bound 
Upper 
Bound     
II 6 1.3933 .03882 .01585 1.3526 1.4341 1.34 1.44 
III 10 1.2580 .03360 .01062 1.2340 1.2820 1.21 1.32 
IV 4 1.1475 .02754 .01377 1.1037 1.1913 1.12 1.18 
Total 20 1.2765 .09511 .02127 1.2320 1.3210 1.12 1.44 
 
     
MULTIPLE COMPARISIONS BETWEEN THE GRADES OF CLEAR 
CELL RCC 
(I) CC 
RCC 
(J) CC 
RCC 
Mean 
Differen
ce (I-J) 
Std. 
Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
II III .1353(*) .01770 .001 .0899 .1807 
IV .2458(*) .02212 .001 .1891 .3026 
III II -
.1353(*) 
.01770 .001 -.1807 -.0899 
  IV .1105(*) .02028 .001 .0585 .1625 
IV II -
.2458(*) 
.02212 .001 -.3026 -.1891 
  III -
.1105(*) 
.02028 .001 -.1625 -.0585 
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  COMPARISION OF T STAGING AND THE ADC VALUE 
 N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minim
um 
Maxim
um 
          
Lower 
Bound 
Upper 
Bound     
T1 3 1.5633 .24664 .14240 .9506 2.1760 1.28 1.73 
T2 8 1.3838 .17054 .06030 1.2412 1.5263 1.18 1.76 
T3 19 1.4026 .23168 .05315 1.2910 1.5143 1.12 1.81 
Tot
al 
30 1.4137 .21720 .03966 1.3326 1.4948 1.12 1.81 
 
 
STAGING AND ADC VALUE SIGNIFICANCE 
 
Sum of 
Square
s df 
Mean 
Square F Sig. 
Between 
Groups 
.077 2 .038 .802 .459 
Within 
Groups 
1.291 27 .048     
Total 1.368 29       
 
    There  is no statistical significance between the T stage  and the ADC value                                               
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                                                      DISCUSSION 
RCC is usally diagnosed by CECT  KUB or  contrast MRI scan.But when 
there is an extensively necrotic or renal mass that is cystic in appearance, this may 
have  minimal  enhancement , and the diagnosis of a tumor and a benign complex 
cyst  may overlap . 
So to avoid these circumstances diffusion weighted MRI has come into 
vogue nowadays to establish a reliable diagnosis.This diagnostic imaging is proved 
beyond doubt in neurosurgery in establishing the diagnosis. The practical value of 
the imaging is that, it is used  to differentiate between the tumors and   ischemia 
which occurs in acute stroke patients. 
Similarly Namimoto  has found that the ADCs of malignant masses is 
significantly lower than the ADCs of  benign lesions of the liver. Investigators 
from  other studies also show that there is a different ADC value for hepatic 
metastases, hepatic hemangiomas, and hepatocellular carcinomas . 
Our study results state that the renal mass lesions has different ADC values 
for different lesions because of the change in tissue contents.This different ADC 
values  are due to the different diffusion characterstics in renal mass lesions.The 
necrotic or cystic tumor areas have higher ADC values than that of the solid tumor 
tissue. The  T1 signal appearances  of a lesion is also related to the ADC values  of 
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the lesion. So  T1 hypointense cysts have higher ADC value  than  T1 hyperintense 
cysts, and viceversa. The reason for the  association between T 1 and the ADC 
value is not known. This may be due to the presence of either high protein content 
in the cyst or blood in the cyst that leads to high T1signal in the mass lesions.  
Benign  renal mass and necrotic or renal tumor areas have significantly 
different ADC.This is  because ,in the unhealthy, avascular necrotic  s tumors  
there is restricted water diffusion unlike the cystic renal masses like hydatid 
cyst,hydronephrosis. So, the ADC value  can be used as a supportive and an 
important marker for characterizing  renal mass  lesions.  
  Squillaci , in a study which included benign and malignant cystic mass 
lesions ,have shown results similar to our study. The mean ADC value of the RCC 
masses were 1.7 x10
-3 
mm
2
/s and that for simple cysts mean ADC was  3.65 x10
-3 
mm
2
/s thus demonstrating a significantly higher value for the benign cystic masses. 
           Zhang  has   studied the DW  MRI imaging to evaluate 25 Cystic and solid 
renal mass lesions. Larger areas of interest was  taken by them for the 
measurement of the ADC value.Their ADC measurement represented the entire 
mass.Thereafter, based on the contrast-enhanced MR report, they divided the 
lesion into solid and cystic necrotic parts. Zhang  had the report of  lower ADC 
value in the intra cystic necrotic portions  of neoplasms when compared to the  
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ADCvalue  in simple cysts.Their study did not mention the differences in ADC 
based on histology subtype of  RCC. In our study, we  measured the ADC in the 
entire mass lesion ( in two to four images so that it covers the entire lesion) as well 
as the cystic and solid portions of cystic RCCs. 
In our study, the mean ADC value  of high grade tumors (Fuhrman grade III 
& IV) were significantly lower than that of low grade tumors in the clear cell RCC 
group. This is because of the restricted diffusion in the high grade tumors .Thus 
ADC value could also add to the prognosis of tumors when the grade of the tumors 
is determined.  
  In our study, in  one case, even though there was a high signal in T1 there is 
higher ADC value  due to the non restricted diffusion of the molecules in the 
simple cyst and the ADC value correlated  with the HPE report. Different 
considerations have to be made for clear cell carcinoma and non clear cell 
carcinoma.In the non clear cell carcinoma ,these tumors form trabecular structures, 
nests and tubular formations  containing large interstitial spaces where  there is 
water and molecules can move freely. In  our study, the mean ADC values of clear 
cell carcinoma and non clear cell carcinoma were 1.27 x10
-3 
mm
2
/s and 1.68 x10
-3 
mm
2
/s  respectively .On data analysis they were found to be statiscally significant. . 
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A meta-analysis of 99 studies was done previously to know whether all renal 
tumours that are diagnosed should be subjected to surgical management. It stated 
that active surveillance can be done in selected cases so that there is no 
intermediate survival benefit when surgical modalities are considered.There is no 
increase in the local recurrence when the patients are under surveillance. The study 
had a good follow up period of about 4 years. So based on this results we can 
suggest that when there is a role for surveillance,where the histology and the grade 
of the tumor is to be known preoperatively, this specialized MR imaging can be 
done. 
Also for the start of the targeted therapy, the histology of the RCC should be 
known in the case of metastatic disease. Sunitinib is  more effective in  clear cell 
RCC and it is the first line drug ,whereas the mTOR inhibitors   like Temsirolimus 
is  used for non clear cell RCC. 
The mean value of angiolipomas in our study is  1.83x 10
-3
mm
2
/s. 
           This ADC value differs from that of the other benign renal mass lesions of 
the kidney . Angiomyolipoma, as known, is composed  of differing amounts of 
smooth muscle, fat  and  good vasculature with a significant cellularity .Because it 
also has with it, a  collagenous  interstitial stroma ,which reduces water diffusion 
velocity, the ADC values in the renal mass lesion is low than that of other benign 
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lesions. But the diagnosis of  AML can be made readily on  MRI with in and out of 
phase sequencing imaging.  
When there is a lowered creatinine clearance ,where the contrast cannot be 
used, there arises a difficulty in the differentiation whether it is hydronephrosis or 
pyonephrosis, which utilizes the DW MRI .This has been investigated in prior 
studies .  
            Currently, MRI is considered the only imaging modality which is capable 
of measuring in vivo diffusion of molecules. Because of its high blood flow and 
basic function of fluid management , that justify high ADC values, the kidney is an 
ideal organ for DWI MR. The mean ADC value of normal renal parenchyma was 
2.34±0.12 x 10 -3 mm 2 /sec .The variability of different ADC values is due to 
different MR techniques, and the different diffusion weightings used for the 
imaging  sequence, which is denoted by the b factor value, encompassing the main 
characteristics of diffusion gradients (amplitude, duration and time interval 
between gradients). 
The ideal diffusion weighting of an echoplanar sequence is still not 
conclusive by the experts. When the low b factor values (30-100 s/mm 2 ) are used, 
the perfusion of the microcircle and the T2 tissue components ,there will be  an 
overestimation of ADC values. Contrarily , the use of high b factor values (>1000 
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s/mm 2 ) there will be more  noisy images due to the low MR signal which is due 
to  the short T2 time.So in our study the diffusion weighted imaging sequence is 
the average of three b values thereby reducing the errors in measuring the ADC 
value. 
One limitation of the study was that the study did not evaluate the  tumor 
cellularity in histopathological report. 
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                                                     CONCLUSION 
 
In conclusion, our study states that  Diffusion weighted MR imaging can be 
used in the management of renal masses, more so to differentiate between  benign 
mass  lesions from renal cell cancer.  
The  histologic subtype of  RCC can be diagnosed pre op from the ADC 
values and can guide targeted therapy. 
It also establishes the grade of the tumor in clear cell RCC thereby prognosis 
of the disease is known. 
When the use of contrast is contraindicated, such as  gadolinium, there is a 
role for DWI  in the diagnosis of  malignant renal masses.  
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                                                      APPENDIX  I 
                                 INFORMED CONSENT FORM 
 
Title of the study: 
 
DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING IN 
RENAL MASSES 
 
Name of the Participant: 
 
Name of the Principal Investigator: Dr. MOHANKUMAR.D 
 
Name of the Institution: Rajiv Gandhi Govt.General Hospital, Chennai -3. 
 
Documentation of the informed consent 
 
I _____________________________ have read the information in this form 
(or it has been read to me). I was free to ask any questions and they have 
been answered. I am over 18 years of age and, exercising my free power of 
choice, hereby give my consent to be included as a participant in  
  
DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING IN 
RENAL MASSES 
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1. I have read and understood this consent form and the information provided to 
me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the investigator. 
5. I have been informed the investigator of all the treatments I am taking or have 
taken in the past 3 months including any native (alternative) treatment. 
6. I have been advised about the risks associated with my participation in this 
study. 
7. I agree to cooperate with the investigator and I will inform him/her immediately 
if I suffer unusual symptoms. 
8. I have not participated in any research study within the past 6 month(s) 
10. I am aware of the fact that I can opt out of the study at any time without having 
to give any reason and this will not affect my future treatment in this hospital. 
11. I am also aware that the investigator may terminate my participation in the 
study at any time, for any reason, without my consent. 
12. I hereby give permission to the investigators to release the information 
obtained from me as result of participation in this study to the regulatory 
authorities, Govt. agencies, and IEC. I understand that they are publicly presented. 
13. I have understand that my identity will be kept confidential if my data are 
publicly presented 
14. I have had my questions answered to my satisfaction. 
15. I have decided to be in the research study. 
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I am aware that if I have any question during this study, I should contact the 
investigator. By signing this consent form I attest that the information given in this 
document has been clearly explained to me and understood by me, I will be given a 
copy of this consent document. 
 
For adult participants: 
 
Name and signature / thumb impression of the participant (or legal representative if 
participant incompetent) 
 
Name _________________________ Signature_________________ 
 
Date________________ 
 
Name and Signature of impartial witness (required for illiterate patients): 
Name _________________________ Signature_________________ 
Date________________ 
 
Address and contact number of the impartial witness: 
Name and Signature of the investigator or his representative obtaining consent: 
Name _________________________ Signature_________________ 
Date________________ 
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                                                   APPENDIX  II 
TITLE:DIFFUSION WEIGHTED MAGNETIC RESONANCE  IMAGING 
IN RENAL MASSES 
                                               PROFORMA 
NAME: 
AGE: 
SEX: 
IP NO: 
PRESENTING COMPLAINTS: 
 
 
BASIC INVESTIGATIONS: 
 
USG KUB: 
CECT KUB: 
 
DIFFUSION WEIGHTED MRI: 
 
PROCEDURE DONE: 
 
POST OP HPE REPORT: 
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APPENDIX III    MASTER CHART 
     
s.NO NAME AGE/SEX IP NO DIAGNOSIS STAGE 
ADC 
VALUE PROCEDURE HPE REPORT 
1 KANNAN 63/M 113662 LT RENAL MASS T3aN1M0 1.13 LT RAD NEP CC RCC GRADE 1V 
2 JEYARAMAN 60/M 79111 RT RENAL MASS T3bN1M0 1.26 
RT RAD 
NEPH  CC RCC GRADE III 
3 PATCHAIAMMAL 81/F 55442 RT RENAL MASS T2N0M0 1.32 
RT RAD 
NEPH CC RCC GRADE III 
4 VALLIYAMAL 45/F 32614 LT RENAL MASS T2N0M0 1.34 
LT RAD 
NEPH CC RCC GRADE II 
5 PARVATHY 40/F 22234 RT RENAL MASS T3aN1M0 1.53 
RT RAD 
NEPH CHROMO GRADE II 
6 CHINNAPILLAI 50/F 12347 RT RENAL MASS T3AN0M0 1.23 RT RAD NEP CC RCC GRADE III 
7 VEERABATHIRAN 49/M 17112 LT RENAL MASS T3aN0MO 1.43 RT RAD NEP CCRCC GRADE II 
8 SRINIVASAN 48/M 92357 RT RENAL MASS T2N0MO0 1.36 LT RAD NEP CC RCC GRADE II 
9 KRISHNAVENI 60/F 87124 LT RENAL HYDATID CYST   2.52 LT NEPH HYDATID CYST 
10 SATHYA 43/F 66164 LT XGPN   2.78 LT NEPH XGPN 
11 VEERARAHAVAN 59/M 72343 RT METS RCC T3aNOM1 1.76 
RT CYT 
NEPH UNCLASSIFIED RCC III 
12 SANJEEVAMMAL 44/F 11185 RT RENAL HYDATID CYST   2.74 RT NEPH HYDATID CYST 
13 MUTHUSWAMY 77/M 79737 RT RENAL MASS T2aNOMO 1.28 
RT RAD 
NEPH CC RCC GRADE III 
14 SHANMUGASUNDHARAM 50/M 29227 RT XGPN   2.64 RT NEPH XGPN 
15 MEHUMUDA 72/F 63441 LT RENAL MASS T1bNOMO 1.73 LT RAD NEP PAPILLARY CA GRADE II 
16 ALIS BAGYAVATHI 53/F 10822 RT RENAL MASS T2N1M1 1.18 
RT CYT 
NEPH CC RCC GRADE IV 
17 BANUMATHI 48/F 104911 RT RENAL MASS T3bN1M0 1.16 
RT RAD 
NEPH CC RCC GRADE IV 
18 ALAMELU 40/F 98976 RT RENAL MASS T2N0M0 1.39 
RT RAD 
NEPH CC RCC GRADE II 
19 BALADHANDAYUTHAM 51/M 89112 RT RENAL MASS T1bNOMO 1.68 
RT RAD 
NEPH CHROMOPHOBE GRADE III 
20 PONNUSAMY 49/M 22799 LT RENAL MASS T3aN0M0 1.4 LT RAD NEP CC RCC GRADE II 
21 RAJAM 59/M 13057 RT METS RCC T3aN1M1 1.21 
RT CYT 
NEPH CC RCC GRADE III 
22 PANNER 72/M 11476 LT RENAL MASS T3aN1M1 1.81 LT RAD NEP PAPILLARY CA GRADE II 
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23 MOHAN 50/M 29217 RT XGPN   2.84 RT NEPH XGPN 
24 SHANTHI 60/F 56442 RT RENAL MASS T2bN1M0 1.76 
RT RAD 
NEPH CHROMOPHOBE GRADE IV 
25 SUBRAMANI 65/M 73289 LT RENAL MASS T3bN1M0 1.28 
LT RAD 
NEPH CC RCC GRADE III 
26 KALA 35/F 12865 LT AML   1.84 LT NEPH AML 
27 HARIDOSS 50/M 19171 RT RENAL MASS T3bN1M0 1.26 
RT RAD 
NEPH CC RCC GRADE III 
28 PANCHALAI 60/F 13262 AML LT   1.96 LT NEPH AML 
29 KASTHURI 35/F 81532 LT XGPN   2.76 LT NEPH XGPN 
30 POOVARASAN 48/M 20117 RT RENAL MASS T3aN0M1 1.12 
RT CYT 
NEPH CC RCC GRADE IV 
31 MUNIYAMMAL 48/F 59253 AMLRT   1.68 RT NEPH AML 
32 VATCHALA 54/F 51842 LT RENAL MASS T2bN1M0 1.44 
LT RAD 
NEPH CC RCC GRADE II 
33 VASANTHI 43/F 21238 BOS III CYST   2.5 RT NEPH SIMPLE CYST 
34 ANNAKILI 59/F 45001 RT RENAL MASS T3aN0M0 1.63 
RT RAD 
NEPH COLL DUCT RCC III 
35 DILLI BABU 60/M 24735 RT RENAL MASS T3aN0M0 1.74 
RT RAD 
NEPH PAPILLARY CA GRADE IV 
36 RAJAM 51/M 14254 RT METS RCC T3aN1M1 1.22 
RT CYT 
NEPH CC RCC GRADE III 
37 SALAMMOL 46/F 86848 LT RENAL MASS T3aN1M1 1.62 
LT RAD 
NEPH PAPILLARY CA GRADE IV 
38 SUBBURAMAN 65/M 73289 LT METS RCC T3aN0M1 1.24 
LT CYT 
NEPH CCRCC GRADE III 
39 RAHAMA ULLAH 52/M 51751 RT RENAL MASS T1bN1M1 1.28 
RT RAD 
NEPH CC RCC GRADE III 
40 ANIKI REDDY 65/M 51732 RT RENAL MASS T3aN1M1 1.62 
LT CYT 
NEPH CHROMOPHOB GRADE IV 
 
 
 
 
MuhŒ¢á x¥òjš got« 
MuhŒ¢á jiy¥ò 
“gutš fd¤j fhªj x¤jâ®î glkh¡fš _y«  
áWÚuf f£ofis m¿tj‰fhd MŒî” 
MuhŒ¢á Ãiya« : áWÚÇaš Jiw,  
br‹id kU¤Jt¡ fšÿÇ k‰W« 
uhé› fhªâ muR bghJ kU¤Jtkid, br‹id. 
g§F bgWtÇ‹ bga® : 
ghÈd« : 
g§FbgwgtÇ‹ v© : 
g§F bgWgt® ïjid () F¿¡fî« 
nkny F¿¥ã£LŸs kU¤Jt MŒÉ‹ Étu§fŸ vd¡F És¡f¥g£lJ. 
v‹Dila rªnjf§fis nf£fî«, mj‰fhd jFªj És¡f§fis bgwî« 
thŒ¥gË¡f¥g£lJ. 
eh‹ ï›thŒÉš j‹Å¢irahfjh‹ g§nf‰»nw‹. vªj fhuz¤âdhnyh 
vªj f£l¤âY« vªj r£l á¡fY¡F« c£glhkš eh‹ ï›thŒÉš ïUªJ Éy» 
bfhŸsyh« v‹W« m¿ªJ bfh©nl‹. 
ïªj MŒî r«gªjkhfnth, ïij rh®ªj nkY« MŒî nk‰bfhŸS« nghJ« 
ïªj MŒÉš g§FbgW« kU¤Jt® v‹Dila kU¤Jt m¿¡iffis gh®¥gj‰F v‹ 
mDkâ njitÆšiy vd m¿ªJ bfhŸ»nw‹. eh‹ MŒÉš ïUªJ Éy»¡ 
bfh©lhY« ïJ bghUªJ« vd m¿»nw‹.  
ïªj MŒÉ‹ _y« »il¡F« jftšfisí«, gÇnrhjid Koîfisí« 
k‰W« á»¢ir bjhl®ghd jftšfisí« kU¤Jt® nk‰bfhŸS« MŒÉš 
ga‹gL¤â¡bfhŸsî« mij ãuRÇ¡fî« v‹ KG kdJl‹ r«kâ¡»‹nw‹.  
ïªj MŒÉš g§F bfhŸs x¥ò¡bfhŸ»nw‹. vd¡F bfhL¡f¥g£l 
m¿îiufË‹go elªJ bfhŸtJl‹ ïªj MŒit nk‰bfhŸS« kU¤Jt mÂ¡F 
c©ikíl‹ ïU¥ng‹ v‹W cWâaË»nw‹. vdJ clš ey«ghâ¡f¥g£lhnyh 
mšyJ vâ®ghuhj tH¡fâ‰F khwhd nehŒ¡F¿ bj‹g£lhnyh clnd mij kU¤J 
mÂÆl« bjÇÉ¥ng‹ vd cWâ mË¡»nw‹. 
ïªj MŒÉš vd¡F ïu¤j«, áWÚ®, v¡Þnu, Þnf‹ k‰W« jir gÇnrhjid 
brŒJbfhŸs eh‹ KG kdJl‹ r«kâ¡»nw‹. 
 
g§nf‰gtÇ‹ ifbah¥g« ……..……….. ïl«…………….. njâ…………… 
f£ilÉuš nuif 
g§nf‰gtÇ‹ bga® k‰W« Éyhr« …………………………………………… 
MŒthsÇ‹ ifbah¥g« ……………….. ïl«…………….. njâ……………. 
MŒthsÇ‹ bga® ………………………………………… 
jftš got« 
cga¤jh®  : ïšiy 
MŒths® bga®  :  
g§nf‰ghs® bga®  : 
MŒî brŒa¥gL« jiy¥ò : gutš fd¤j fhªj x¤jâ®î glkh¡fš 
_y« áWÚuf f£ofis m¿tj‰fhd 
MŒî 
1. ïªj MŒî  
j§fS¡F áWÚfu¤âš f£o V‰g£L cŸsJ. mj‰F á»¢ir 
mË¡F« K‹ c§fË‹ nehŒ¡F¿a f£l¤ij m¿a nt©o cŸsJ. 
mj‹bghU£L jh§fŸ gutš fd¤j fhªj x¤jâ®î glkh¡fš _y« 
gÇnrhjid brŒJ nehŒF¿ f£l¤ij m¿ayh«. vdnt mj‰fhf gutš 
fd¤j fhªj x¤jâ®î glkh¡fš MŒÉ‰F r«kj« jUkhW bjÇÉ¤J¡ 
bfhŸ»nw‹.  
ïªj MŒÉš g§FbgWtJ nehahËfË‹ brhªj ÉU¥g¤ânyna 
MF«. ïªj MŒitbah£o vªjÉjkhd rªnjf§fS¡F« És¡f« bgw 
nehahËfS¡F cÇik cŸsJ. ïªj MŒÉ‹ KoîfŸ ïWâÆš 
ãuRÇ¡f¥gL«. 
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